Company Overview: Stryker Corporation is a medical device and surgical instruments manufacturer incorporated in Michigan, headquartered in Portage, MI, operating in the surgical and medical instruments industry (SIC 3841) Financial Reporting Period: Annual report for fiscal year ended December 31, 2025, filed February 11, 2026, covering full-year 2025 financial performance and position Capital…

Our analysis rates this filing CAUTIOUS. Stryker Corporation presents an elevated but manageable concern profile. The most significant issue is the recurring pattern of goodwill impairment charges across three consecutive years spanning multiple business segments (Med Surg & Neurotechnology,…

Concern level: ELEVATED (5.8/10). Key factors: Recurring goodwill impairment charges across three consecutive years (2023-2025) in multiple segments indicating persistent M&A integration challenges and valuation deterioration; Goodwill impairment pattern suggests structural acquisition strategy issues rather than isolated one-time events, requiring strategic reassessment; Debt maturity…

Notable risk changes: Goodwill impairment charges recorded across multiple segments in 2025 (continuing pattern from 2024 and 2023), indicating persistent challenges with acquired asset valuations and integration; Significant operating lease obligations and right-of-use assets recorded, reflecting substantial real estate and equipment commitments that impact balance sheet and cash flow flexibility; Debt maturity…

The model predicts SYK will underperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.